4-Year Longitudinal Study Of Efficacy And Safety Of Premium Intraocular Lenses In Cataract Surgery
Published 2023 - 41st Congress of the ESCRS
Reference: PP10.10 | DOI: 10.82333/m7dh-yt29
Authors: Demetrios Pirounides 1 , George Balanikas 1 , Eleni Papadopoulou* 1 , Iordanis Vagiakis 1 , Panagiotis Ageladarakis 1 , Aikaterini Tsilingiri 2
1Ophthalmology,AHEPA,Thessaloniki,Greece, 2Ophthalmology,General Hospital of Xanthi,Xanthi,Greece
To assess the perioperative outcomes and spectacle independence and investigate the onset of any adverse effects of premium intraocular lens (IOL) implantation following phacoemulsification.
Department of Ophthalmology, AHEPA University Hospital.
Retrospective, hospital-based, chart review analyses of patients, without ocular comorbidities, who have undergone cataract extraction with intraocular lens implantation by a single surgeon. The patients implanted with multifocal (Alcon Laboratories, AcrySof IQ PanOptix, model TFNT00; 4 patients), advanced monofocal (TECNIS Eyhance IOL; model ICB00/DIB; 7 patients), , or toric (Alcon Laboratories, AcrySof IQ model Toric SN6ATT; 9 patients) IOLs.
20 eyes of 1163 patients with premium IOL implantation from 2019 to 2023 were identified. Patient ages ranged from 44 to 82 years. Although both the postoperative uncorrected distance and intermediate visual acuity at 1 week and 1 month were improved in all groups, near visual acuity was higher in the multifocal group. 85% of advanced monofocal IOLs showed a postoperative spherical equivalent within ±0.50 D diopters (D) while at the same group, a total of 100% and 85% of eyes showed UDVA and UIVA of 6/7.5 or better, respectively. There were no significant differences between the advanced monofocal and the toric groups in terms of photopic contrast sensitivity while glare and halo perception were more prevalent in the multifocal group.
In patients without ocular comorbidities, premium IOL implantation may result to reasonable rates of spectacle independence and a low incidence of visual phenomena. Multifocal IOLs are effective at improving near vision relative to monofocal IOLs. Multifocal and enhanced monofocal IOLs provide a greater depth of focus. All three IOLs provided great UDVA contributing to patient daily functioning. Compared to the two other groups, multifocal IOLs provide better near vision. Toric intraocular lenses is an effective option when they are utilized for patients with astigmatism. Vigilant preoperative assessment is the key for accurate results, leading to right patient selection for premium IOLs.